It enables speed of installation through on-site assembly of prefabricated and pre-assembled parts in a safe and controlled manner.
He is committed to the betterment of lives through individual and collective endeavours.. As well as his business and pharmaceutical experience, Dyson is Professor of Human Enterprise at the University of Birmingham, focussing on project management, business strategy and collaboration.. Additionally, he is a qualified counsellor with a private practice and looks to bring the understanding of human behaviour into business and projects.. To learn more about our Design to Value philosophy, read Design to Value: The architecture of holistic design and creative technology by Professor John Dyson, Mark Bryden, Jaimie Johnston MBE and Martin Wood.Available to purchase at.'Transforming Small Molecule API Manufacturing' explores the innovative strides being made towards more efficient, sustainable, and cost-effective drug production.. Adrian La Porta.
shares his insights on the pivotal role of miniaturisation and automation in shaping the future of Active Pharmaceutical Ingredients (APIs) production, highlighting the potential for significant industry transformation.. Watch now for a unique perspective on how modern advancements are paving the way for a new era in pharmaceuticals, not only redefining manufacturing processes but also promising a healthier future for all.Presented by our Head of Sustainability, Helen Hough, this video takes you on a journey through the development of The Forge, a landmark London project that represents a significant leap in sustainable construction..Discover the pioneering use of a platforms approach to Design for Manufacture and Assembly (P-DfMA) and how it contributed to a remarkable reduction in whole-life carbon emissions..Through Helen's expert insights, learn about the collaborative efforts and innovative strategies that make The Forge a model for future construction projects aiming for environmental excellence.Through this 'In Short' episode,.
delves into the challenges and breakthroughs in pharmaceutical manufacturing, exploring how new approaches like process intensification, automation, and continuous processing can lead to more agile, cost-effective, and environmentally friendly production methods.. Click the 'play button' above to listen in, or read our 5 Key Takeaways from this episode below.... 1.Revolution in small molecule API production:.
The episode highlights the transformative research and development in small molecule Active Pharmaceutical Ingredients, emphasising the generation of new, more complex, and targeted molecules.
This revolution is pivotal for advancing the mainstay of essential medicines globally.. 2.Each industrialised construction technique is just another tool in the toolkit, with varying degrees of suitability depending on the particular scenario.. She also raises the point that some people feel threatened by the industrialised construction terminology, as a result of not having the necessary skill set.
As a result, they become very opposed.This presents an additional challenge.. Marks says it’s particularly problematic due to the siloed nature of the ecosystem.
She doesn’t want the language of industrialised construction to hold anyone back, or create barriers, and feels it’s simply a matter of adapting and changing a few behaviors.. Prioritising Design to Value with lean construction principles.Jaimie Johnston recognises that people are becoming bogged down in the granularity of the words, even with terms like ‘on-site’ and ‘off-site.’.